Dodda Sundararaju, Polavarapu Sujatha, Alluri Krishnaraju Venkata, Golakoti Trimurtulu, Sengupta Krishanu
Department of Toxicology, Laila Nutraceuticals R&D Center, Vijayawada, Andhra Pradesh, India.
J Toxicol. 2024 Nov 27;2024:4239607. doi: 10.1155/jt/4239607. eCollection 2024.
LN19183 is a standardized composition of (Christm) Swingle (CA) fruit rind and L. (TC) seed extracts that have recently been demonstrated to increase resting energy expenditure (REE) and reduce body fat in rats. CA and TC are important herbs in traditional medicine for various health benefits. The present study evaluates the comprehensive toxicity of LN19183 in acute, subchronic, and genetic toxicity studies following the guidelines of the Organization for Economic Co-operation and Development (OECD) for testing chemicals. The acute oral and dermal and 90-day subchronic oral toxicities were performed in rats, and acute dermal and eye irritations were performed in rabbits. In the subchronic toxicity study with a 28-day recovery period, male and female Sprague Dawley rats were orally gavaged with daily LN19183 doses of 500, 1000, or 2000 mg/kg body weight (BW). Furthermore, the genetic toxicity studies included mutagenicity in bacteria, chromosome aberration, and micronucleus assays in human blood mononuclear cells in vitro and micronucleus assay in Swiss albino mice bone marrow in vivo. Acute and subchronic repeat dose oral toxicity studies showed no adverse events, clinical signs, or mortality. All animals exhibited normal food and water intake and natural BW gain. In the 90-day study, LN19183 did not induce major changes in hematology, biochemical evaluations, and urine analysis; gross and histopathological findings did not show any treatment-related lesions or abnormality. The no observed adverse effect level (NOAEL) of LN19183 supplementation was 2000 mg/kg BW/day. In the genetic toxicity studies, LN19183 treatment did not show significant increases in the revertant bacterial colonies, chromosomal aberrations, or number of micronucleated cells. The present observations affirm that oral consumption of LN19183 is safe, and this botanical composition is nonmutagenic and nonclastogenic.
LN19183是一种标准化组合物,由(圣诞)斯文格(加利福尼亚)果皮和罗勒种子提取物组成,最近已证明其可增加大鼠的静息能量消耗(REE)并减少体脂。加利福尼亚和罗勒是传统医学中具有多种健康益处的重要草药。本研究按照经济合作与发展组织(OECD)测试化学品的指南,评估了LN19183在急性、亚慢性和遗传毒性研究中的综合毒性。在大鼠中进行了急性经口和经皮毒性以及90天亚慢性经口毒性试验,并在兔子中进行了急性经皮和眼刺激性试验。在有28天恢复期的亚慢性毒性研究中,对雄性和雌性斯普拉格·道利大鼠每日经口灌胃给予500、1000或2000毫克/千克体重(BW)的LN19183剂量。此外,遗传毒性研究包括细菌致突变性、染色体畸变以及体外人血单核细胞微核试验和体内瑞士白化小鼠骨髓微核试验。急性和亚慢性重复剂量经口毒性研究未显示不良事件、临床体征或死亡。所有动物的食物和水摄入量正常,体重自然增加。在90天的研究中,LN19183未引起血液学、生化评估和尿液分析的重大变化;大体和组织病理学检查结果未显示任何与治疗相关的病变或异常。补充LN19183的未观察到有害作用水平(NOAEL)为2000毫克/千克体重/天。在遗传毒性研究中,LN19183处理未显示回复突变细菌菌落、染色体畸变或微核细胞数量有显著增加。目前的观察结果证实,口服LN19183是安全的,这种植物组合物无致突变性和断裂作用。